|
Market Cap | 3.85M | EPS (ttm) | -12.01 |
P/E | - | EPS this Y | 76.49% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.69 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 63.78% |
Dividend | - | Sales Q/Q | -5.40% |
Insider Own | 30.95% | Inst Own | 4.08% |
Insider Trans | 388.58% | Inst Trans | - |
Short Float | 4.01% | Earnings | Mar 26/a |
Analyst Recom | 3.00 | Target Price | 3.00 |
Avg Volume | 137.14K | 52W Range | 1.52 - 39.60 |
|
|
Apr-25-24 01:54PM
|
Hedge Fund and Insider Trading News: Anthony Scaramucci, Sanjay Shah, David Einhorn, Bill Ackman, Engine Capital, Appaloosa Management, Jefferies Financial Group Inc (JEF), Intrusion Inc. (INTZ), and More
(Insider Monkey) +7.26% |
11:00AM
|
CEO Anthony Scott Acquires 585,748 Shares of Intrusion Inc (INTZ)
(GuruFocus.com) |
Apr-23-24 08:37AM
|
Intrusion (INTZ) Announces Purchase of Stake in Klever AI
(Zacks) +11.87% |
Apr-22-24 05:30PM
|
Intrusion Inc. Announces Private Placement Subscription Agreement
(ACCESSWIRE) -5.88% |
08:00AM
|
Intrusion Inc. Announces Acquisition of Minority Stake in Klever AI
(ACCESSWIRE) |
Apr-17-24 09:15AM
|
Intrusion Partner iOne Wins P1.4 Billion Bid for the Commission on Elections Project, Securing National and Local Polls in the Philippines
(ACCESSWIRE) -15.65% |
Apr-12-24 12:00PM
|
Intrusion (INTZ) Upgraded to Strong Buy: What Does It Mean for the Stock?
(Zacks) +6.59% |
Apr-11-24 12:39PM
|
The Next Big Thing: 3 Tech Titans to Surge 500% by 2027
(InvestorPlace) |
Mar-27-24 12:15PM
|
Intrusion Inc. (NASDAQ:INTZ) Q4 2023 Earnings Call Transcript
(Insider Monkey) -8.85% |
10:22AM
|
Q4 2023 Intrusion Inc Earnings Call
(Thomson Reuters StreetEvents) |
|
Intrusion, Inc. is a cybersecurity company, which offers customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company was founded by T. Joe Head and G. Ward Paxton in September 1983 and is headquartered in Plano, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Scott Anthony | Chief Executive Officer | Apr 22 '24 | Buy | 1.70 | 585,748 | 995,772 | 638,281 | Apr 25 08:11 AM | PINSON KIMBERLY | Chief Financial Officer | Apr 22 '24 | Buy | 1.70 | 10,000 | 17,000 | 15,076 | Apr 25 08:10 AM | LEVECCHIO ANTHONY J | Director | Apr 04 '24 | Option Exercise | 2.91 | 8,334 | 24,252 | 20,611 | Apr 04 06:46 PM | Scott Anthony | Chief Executive Officer | Apr 02 '24 | Option Exercise | 2.91 | 33,334 | 97,002 | 52,533 | Apr 04 06:54 PM | PINSON KIMBERLY | Chief Financial Officer | Apr 02 '24 | Option Exercise | 2.91 | 3,334 | 9,702 | 5,076 | Apr 04 06:51 PM |
|
|
|
|
Market Cap | 71.82M | EPS (ttm) | -19.67 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 10.66% |
P/S | 378.02 | EPS next 5Y | - |
P/B | 5.44 | EPS Q/Q | 82.28% |
Dividend | - | Sales Q/Q | -72.96% |
Insider Own | 18.55% | Inst Own | 12.65% |
Insider Trans | 17.09% | Inst Trans | -41.48% |
Short Float | 3.65% | Earnings | Mar 20/a |
Analyst Recom | - | Target Price | - |
Avg Volume | 25.98K | 52W Range | 2.45 - 13.63 |
|
|
|
authID, Inc. engages in the delivery of secure, mobile, and biometric identity solutions. It operates through the Verified Authentication Business segment. The company was founded by Thomas R Snoke on September 21, 2011 and is headquartered in Denver, CO. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Garchik Stephen Jeffrey | 10% Owner | Apr 23 '24 | Buy | 6.85 | 12,000 | 82,200 | 1,163,096 | Apr 25 08:00 AM | Garchik Stephen Jeffrey | 10% Owner | Apr 12 '24 | Buy | 7.69 | 10,500 | 80,745 | 1,151,096 | Apr 15 05:15 PM | Garchik Stephen Jeffrey | 10% Owner | Jan 31 '24 | Buy | 9.40 | 5,700 | 53,580 | 1,140,596 | Feb 01 07:00 PM | Garchik Stephen Jeffrey | 10% Owner | Jan 30 '24 | Buy | 9.10 | 2,500 | 22,750 | 1,134,896 | Jan 30 08:25 PM | Garchik Stephen Jeffrey | 10% Owner | Jan 25 '24 | Buy | 9.40 | 1,000 | 9,400 | 1,132,396 | Jan 26 06:08 AM |
|
|
|
|
Market Cap | 3.39B | EPS (ttm) | -5.67 |
P/E | - | EPS this Y | -10.17% |
Forward P/E | - | EPS next Y | 7.57% |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 7.36 | EPS Q/Q | 38.59% |
Dividend | - | Sales Q/Q | - |
Insider Own | 14.64% | Inst Own | 82.88% |
Insider Trans | 3.06% | Inst Trans | 495.97% |
Short Float | 11.48% | Earnings | Feb 29/a |
Analyst Recom | 1.09 | Target Price | 59.33 |
Avg Volume | 1.30M | 52W Range | 12.35 - 62.21 |
|
|
|
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Bailey Gregory | Director | Apr 24 '24 | Buy | 39.18 | 25,503 | 999,169 | 1,600,071 | Apr 25 07:32 AM | CHILDS JOHN W | Director | Apr 22 '24 | Buy | 41.00 | 195,121 | 7,999,961 | 4,096,512 | Apr 23 07:54 AM | Coric Vlad | Chief Executive Officer | Apr 22 '24 | Buy | 41.00 | 121,951 | 4,999,991 | 1,788,417 | Apr 23 07:54 AM | Bailey Gregory | Director | Apr 22 '24 | Buy | 41.00 | 48,780 | 1,999,980 | 1,574,568 | Apr 23 07:54 AM | Antonijevic Irina | Director | Dec 29 '23 | Option Exercise | 0.00 | 11,000 | 0 | 13,535 | Dec 29 06:25 PM |
|
|
| |
|
Market Cap | 18.16B | EPS (ttm) | 1.85 |
P/E | 10.68 | EPS this Y | -13.57% |
Forward P/E | 8.99 | EPS next Y | 13.59% |
PEG | - | EPS past 5Y | 6.49% |
P/S | 1.97 | EPS next 5Y | -0.88% |
P/B | 1.18 | EPS Q/Q | -40.72% |
Dividend | 4.86% | Sales Q/Q | 5.04% |
Insider Own | 0.31% | Inst Own | 81.19% |
Insider Trans | 0.76% | Inst Trans | 0.74% |
Short Float | 3.31% | Earnings | Apr 19/b |
Analyst Recom | 2.46 | Target Price | 21.51 |
Avg Volume | 8.74M | 52W Range | 13.72 - 21.08 |
|
|
|
Regions Financial Corp. operates as a bank holding company. It provides traditional commercial, retail and mortgage banking services, as well as other financial services in the fields of investment banking, asset management, trust, mutual funds, securities brokerage, insurance and other financing. The firm operates through the following segments: Corporate Bank, Consumer Bank, Wealth Management, and Other. The Corporate Bank segment represents the commercial banking functions including commercial and industrial, commercial real estate and investor real estate lending. The Consumer Bank segment holds the branch network, including consumer banking products and services related to residential first mortgages, home equity lines and loans, small business loans, indirect loans, consumer credit cards and other consumer loans. The Wealth Management segment offers individuals, businesses, governmental institutions and non-profit entities a range of solutions to help protect, grow and transfer wealth. The Other segment includes the company's treasury function, the securities portfolio, wholesale funding activities, interest rate risk management activities and other corporate functions that are not related to a strategic business unit. The company was founded in 1971 and is headquartered in Birmingham, AL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
RHODES WILLIAM C III | Director | Apr 23 '24 | Buy | 19.37 | 50,000 | 968,500 | 50,000 | Apr 24 07:48 PM | RHODES WILLIAM C III | Director | Apr 17 '24 | Option Exercise | 0.00 | 1,179 | 0 | 1,279 | Apr 19 04:50 PM | Rand Alison S. | Director | Apr 17 '24 | Option Exercise | 0.00 | 4,700 | 0 | 4,800 | Apr 19 04:50 PM | JOHNSON JOIA M | Director | Apr 17 '24 | Option Exercise | 0.00 | 7,460 | 0 | 12,736 | Apr 19 04:50 PM | Hill J Thomas | Director | Apr 17 '24 | Option Exercise | 0.00 | 7,460 | 0 | 30,567 | Apr 19 04:50 PM |
|
|
|
|
Market Cap | 194.41M | EPS (ttm) | -4.39 |
P/E | - | EPS this Y | 50.56% |
Forward P/E | - | EPS next Y | -13.87% |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 3.28 | EPS Q/Q | -641.35% |
Dividend | - | Sales Q/Q | - |
Insider Own | 56.64% | Inst Own | 47.93% |
Insider Trans | -2.54% | Inst Trans | 2.60% |
Short Float | 2.27% | Earnings | Mar 28/b |
Analyst Recom | 1.00 | Target Price | 19.33 |
Avg Volume | 290.47K | 52W Range | 2.00 - 14.00 |
|
|
|
Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Sidhu Someit | Director | Apr 22 '24 | Buy | 3.13 | 1,186,901 | 3,715,000 | 1,186,901 | Apr 24 06:51 PM | Munshi Amit | Director | Apr 22 '24 | Buy | 3.13 | 159,744 | 499,999 | 777,384 | Apr 24 06:52 PM | Howell Michael | See Remarks | Apr 22 '24 | Buy | 3.13 | 7,987 | 24,999 | 7,987 | Apr 24 06:54 PM | Nistala Kiran | Executive Vice President | Apr 22 '24 | Buy | 3.13 | 3,195 | 10,000 | 3,195 | Apr 24 06:53 PM | Thiara Parvinder | Director | Dec 12 '23 | Sale | 4.00 | 2,000,000 | 8,000,000 | 4,801,633 | Dec 14 03:35 PM |
|
|
| |
|
Market Cap | 12.20M | EPS (ttm) | -0.35 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 63.80% |
P/S | - | EPS next 5Y | - |
P/B | 2.98 | EPS Q/Q | -38.87% |
Dividend | - | Sales Q/Q | - |
Insider Own | 21.78% | Inst Own | 2.33% |
Insider Trans | 3.23% | Inst Trans | 17.58% |
Short Float | 0.51% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 178.89K | 52W Range | 0.13 - 0.99 |
|
|
|
GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
SYCOFF DREW | Director | Apr 22 '24 | Buy | 1.26 | 182,540 | 230,000 | 2,951,258 | Apr 24 06:31 PM |
|
|
|
|
Market Cap | 1.75B | EPS (ttm) | -0.15 |
P/E | - | EPS this Y | 548.41% |
Forward P/E | 22.16 | EPS next Y | 81.59% |
PEG | - | EPS past 5Y | - |
P/S | 0.49 | EPS next 5Y | - |
P/B | 2.74 | EPS Q/Q | 37.98% |
Dividend | - | Sales Q/Q | 34.43% |
Insider Own | 12.41% | Inst Own | 61.44% |
Insider Trans | 0.05% | Inst Trans | -0.23% |
Short Float | 15.38% | Earnings | May 02/a |
Analyst Recom | 3.60 | Target Price | 11.29 |
Avg Volume | 2.41M | 52W Range | 7.17 - 15.19 |
|
|
|
Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Rizik Matthew | Director | Apr 24 '24 | Buy | 12.53 | 347 | 4,348 | 697,855 | Apr 24 06:00 PM | Rizik Matthew | Director | Apr 22 '24 | Buy | 11.68 | 375 | 4,380 | 697,508 | Apr 24 06:00 PM | Rizik Matthew | Director | Apr 19 '24 | Buy | 11.53 | 380 | 4,381 | 697,133 | Apr 19 06:01 PM | Rizik Matthew | Director | Apr 17 '24 | Buy | 11.44 | 383 | 4,382 | 696,753 | Apr 17 06:14 PM | Rizik Matthew | Director | Apr 16 '24 | Buy | 11.46 | 375 | 4,298 | 696,370 | Apr 17 06:14 PM |
|
|
| |
|
Market Cap | 1.77B | EPS (ttm) | -0.12 |
P/E | - | EPS this Y | 7.22% |
Forward P/E | 7.41 | EPS next Y | 14.64% |
PEG | - | EPS past 5Y | - |
P/S | 0.44 | EPS next 5Y | 30.50% |
P/B | 3.14 | EPS Q/Q | -541.36% |
Dividend | 4.39% | Sales Q/Q | 2.79% |
Insider Own | 11.94% | Inst Own | 82.52% |
Insider Trans | -0.60% | Inst Trans | -4.15% |
Short Float | 4.01% | Earnings | May 02/b |
Analyst Recom | 1.71 | Target Price | 41.14 |
Avg Volume | 387.83K | 52W Range | 24.58 - 36.17 |
|
|
|
Upbound Group, Inc. engages in the provision of furniture, electronics, appliances, computers, and smartphones through flexible rental purchase agreements. It operates through the following segments: Rent-A-Center Business, Preferred Lease, Mexico, and Franchising. The Rent-A-Center Business segment consists of company-owned rent-to-own stores in the United States and Puerto Rico. The Preferred Lease segment offers an on-site rent-to-own option at a third-party retailer's location. The Mexico segment consists of its company-owned rent-to-own stores in Mexico. The Franchising segment sells rental merchandise to its franchisees. The company was founded by Mark E. Speese on September 16, 1986 and is headquartered in Plano, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
BROWN JEFFREY J | Director | Apr 22 '24 | Buy | 30.68 | 991 | 30,404 | 83,138 | Apr 24 05:10 PM | Blasquez Anthony J | EVP-RAC | Mar 14 '24 | Option Exercise | 25.88 | 12,485 | 323,128 | 71,452 | Mar 18 04:36 PM | Blasquez Anthony J | EVP-RAC | Mar 14 '24 | Sale | 33.18 | 12,485 | 414,252 | 58,967 | Mar 18 04:36 PM | Montrone Ralph T. | EVP, Acima | Feb 28 '24 | Sale | 33.48 | 30,000 | 1,004,400 | 55,074 | Mar 01 04:01 PM | BROWN JEFFREY J | Director | Jan 09 '24 | Buy | 32.94 | 912 | 30,041 | 82,147 | Jan 11 04:42 PM |
|
|
|
|
Market Cap | 490.66M | EPS (ttm) | -63.36 |
P/E | - | EPS this Y | 82.75% |
Forward P/E | - | EPS next Y | 3.18% |
PEG | - | EPS past 5Y | -11.67% |
P/S | - | EPS next 5Y | - |
P/B | 2.89 | EPS Q/Q | 80.13% |
Dividend | - | Sales Q/Q | - |
Insider Own | 35.06% | Inst Own | 49.92% |
Insider Trans | 6.70% | Inst Trans | -31.27% |
Short Float | 2.58% | Earnings | Mar 26/a |
Analyst Recom | 1.00 | Target Price | 130.00 |
Avg Volume | 32.61K | 52W Range | 4.57 - 97.91 |
|
|
|
Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company was founded by Nessan Bermingham, Jean-Francois Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Atlas Venture Opportunity Fund | 10% Owner | Apr 22 '24 | Buy | 56.00 | 17,857 | 999,992 | 195,074 | Apr 23 05:23 PM | New Enterprise Associates 17, | 10% Owner | Apr 22 '24 | Buy | 56.00 | 17,857 | 999,992 | 1,090,793 | Apr 24 05:00 PM | BASKETT FOREST | 10% Owner | Apr 22 '24 | Buy | 56.00 | 17,857 | 999,992 | 1,090,793 | Apr 24 05:00 PM | Chang Carmen | 10% Owner | Apr 22 '24 | Buy | 56.00 | 17,857 | 999,992 | 1,090,793 | Apr 24 05:00 PM | Florence Anthony A. Jr. | 10% Owner | Apr 22 '24 | Buy | 56.00 | 17,857 | 999,992 | 1,090,793 | Apr 24 05:00 PM |
|
|
|
|
Market Cap | 162.95M | EPS (ttm) | 0.47 |
P/E | 36.43 | EPS this Y | 188.89% |
Forward P/E | 17.28 | EPS next Y | 28.21% |
PEG | 1.82 | EPS past 5Y | -15.93% |
P/S | 1.97 | EPS next 5Y | 20.00% |
P/B | 2.38 | EPS Q/Q | 314.69% |
Dividend | 1.62% | Sales Q/Q | 14.08% |
Insider Own | 17.32% | Inst Own | 33.38% |
Insider Trans | 0.08% | Inst Trans | 0.64% |
Short Float | 0.27% | Earnings | Apr 11/b |
Analyst Recom | 1.00 | Target Price | 20.00 |
Avg Volume | 21.00K | 52W Range | 10.08 - 17.55 |
|
|
|
Northern Technologies International Corp. engages in the development and marketing of proprietary environmentally beneficial products and services. It operates through the Natur-Tec and Zerust segments. The Natur-Tec segment manufactures bio-degradable and bio-based plastics for industrial and consumer applications. The Zerust segment provides corrosion mitigation solutions and services to oil, gas, and chemical processing applications. The company was founded in 1970 and is headquartered in Circle Pines, MN. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Kemp Sarah E. | Director | Apr 23 '24 | Buy | 15.70 | 1,275 | 20,018 | 5,760 | Apr 24 04:56 PM | von Falkenhausen Konstantin | Director | Aug 28 '23 | Option Exercise | 7.35 | 8,000 | 58,800 | 15,200 | Aug 28 05:48 PM | Lee Sunggyu | Director | Aug 17 '23 | Option Exercise | 7.35 | 8,000 | 58,800 | 8,000 | Aug 21 04:07 PM | Calderon Nancy E. | Director | Aug 14 '23 | Buy | 13.17 | 500 | 6,585 | 3,062 | Aug 14 04:23 PM | LYNCH G PATRICK | President and CEO | Aug 08 '23 | Option Exercise | 7.35 | 11,610 | 85,334 | 108,893 | Aug 10 04:44 PM |
|
|
|